Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB13789
CAS 1096144-06-7
Chemical Name: PST3.1a; 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl2-oxo-2λ5-[1,2]oxaphosphinane
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $87.75 | Total: $8,775.00 |
1 | 50 | $101.40 | Total: $5,070.00 |
1 | 25 | $118.95 | Total: $2,973.75 |
1 | 10 | $140.40 | Total: $1,404.00 |
1 | 5 | $165.75 | Total: $828.75 |
Molecular Formula | C32H33O6P |
Molecular Weight | 544.58 |
CAS Numbers | 1096144-06-7 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO |
Purity | 98% by HPLC |
Synonym | NSC753859; NSC 753859; PST3.1a |
IUPAC/Chemical Name | 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl2-oxo-2λ5-[1,2]oxaphosphinane |
References | 1) Zahra Hassani et. al., Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation, Mol Cancer Res (2017) 15 (10): 1376–1387. 2) Karen Muyor et. al., MO072: PST3.1A, An Inhibitor of MGAT5 Decreases Renal Fibrosis in a Rat Model of Chronic Kidney Disease , Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May 2022 |
Novel selective inhibitor of the N-acetylglucosamine glycosyltransferase (MGAT5) enzymatic activity